HIRONC

Hironic Co., Ltd., a company specializing in aesthetic medical devices, announced on the 18th that it will showcase its new product, “MIGLOU,” at “KIMES 2026” (Korea International Medical & Hospital Equipment Show), the largest medical device exhibition in Korea.

KIMES is Korea’s premier medical device exhibition, offering a comprehensive look at the latest trends and technologies in the medical industry. It is a major global medical industry event that attracts a massive number of domestic and international medical device companies, medical professionals, and buyers each year. At KIMES 2026, a variety of cutting-edge medical devices and smart healthcare technologies are scheduled to be introduced.

During this exhibition, Hironic plans to capture the attention of domestic and international medical professionals and buyers by showcasing its new product 'MIGLOU' alongside its core lineup of aesthetic medical devices.

MIGLOU is a device designed based on 2.45GHz Ultra-High Frequency (UHF) technology. By applying CNF (Complex Near Focusing) matching technology, it enables highly precise energy delivery to the target area.

Additionally, it features a safety-focused design that utilizes a contact cooling system and built-in handpiece sensors during treatments. Its utility is further enhanced by supporting a variety of handpieces designed for both face and body care.

Throughout the KIMES 2026 exhibition, Hironic plans to directly demonstrate MIGLOU's technological capabilities to medical professionals and buyers through on-site demonstrations and product consultations. Furthermore, as part of its strategy to expand into the global market, Hironic will actively seek collaborative opportunities with international medical professionals and partners, and conduct business meetings with overseas buyers.

An official from Hironic stated, "MIGLOU, which we are unveiling at KIMES 2026, is a device developed to reflect the diverse needs of the aesthetic dermatology market." The official added, "Through continuous research and development, we plan to keep introducing innovative solutions that enhance satisfaction for both medical professionals and patients."

Meanwhile, Hironic has been bolstering its competitiveness in the aesthetic medical device market through ongoing investments in Research and Development (R&D) and the expansion of its global distribution network. The company recently solidified its foundation for growth by securing a strategic investment from Cactus Private Equity (Cactus PE). Building on this momentum, Hironic is expected to continuously drive the development of next-generation technologies in the medical aesthetic field and further expand its presence in the global market.